OBJECTIVE: The aim of this study was to examine the magnitude of poor persistence in treatment among patients with schizophrenia and to identify associated factors. METHODS: All eligible patients (N=216) seen at the University College Hospital in Ibadan, Nigeria, over a five-year period were retrospectively followed up until the time of their last visit. Time to first default was examined by Kaplan-Meier survival analyses. A log-rank test was used to compare survival times for different variables. The contribution of the variables that affected time to default was examined by Cox regression analysis. RESULTS: Only 24% of the sample remained in treatment at the one-year follow-up. Persistence as measured by mean±SE time to all-cause treatment default was 17.80±1.44 weeks. Of several variables examined, including whether patients were taking first- or second-generation antipsychotics, none were found to predict persistence. CONCLUSIONS: Persistence in treatment of patients with a first episode of schizophrenia was low.
OBJECTIVE: The aim of this study was to examine the magnitude of poor persistence in treatment among patients with schizophrenia and to identify associated factors. METHODS: All eligible patients (N=216) seen at the University College Hospital in Ibadan, Nigeria, over a five-year period were retrospectively followed up until the time of their last visit. Time to first default was examined by Kaplan-Meier survival analyses. A log-rank test was used to compare survival times for different variables. The contribution of the variables that affected time to default was examined by Cox regression analysis. RESULTS: Only 24% of the sample remained in treatment at the one-year follow-up. Persistence as measured by mean±SE time to all-cause treatment default was 17.80±1.44 weeks. Of several variables examined, including whether patients were taking first- or second-generation antipsychotics, none were found to predict persistence. CONCLUSIONS: Persistence in treatment of patients with a first episode of schizophrenia was low.
Authors: Jessie Mbwambo; Sylvia Kaaya; Isaac Lema; Carol Blixen; Kristin A Cassidy; Jennifer B Levin; Martha Sajatovic Journal: Heliyon Date: 2019-06-07
Authors: Jessie Mbwambo; Sylvia Kaaya; Isaac Lema; Christopher J Burant; Catherine Magwiza; Kim Madundo; Godwin Njiro; Carol E Blixen; Kristin A Cassidy; Jennifer B Levin; Martha Sajatovic Journal: BMC Psychiatry Date: 2022-01-27 Impact factor: 3.630